Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 1st Edition
This guideline includes the criteria for developing and using epidemiological cutoff values for guiding clinical decisions when testing fungal species and antifungal agent combinations for which there are no breakpoints.
Supplemental tables for M57 are published in CLSI document M57S.
This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of February 2022. The document’s next scheduled review is generally five years after the reaffirmation date.
Chairholder: Barbara D. Alexander, MD, MHS
Date of Publication: April 30, 2016
Order Code PDF: M57Ed1E
ISBN Number: 1-56238-933-5
Order Code Print: M57Ed1
ISBN Number: 1-56238-932-7
M57 Additional Details
A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.